Reviva is a research and development pharmaceutical company with two portfolio compounds targeting nine indications.

25 Apr 2024
RVPH: Full Year 2023 Results

Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
RVPH: Full Year 2023 Results
- Published:
25 Apr 2024 -
Author:
John Vandermosten -
Pages:
10 -
Reviva is a research and development pharmaceutical company with two portfolio compounds targeting nine indications.